Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 14, 2018 - Issue
Submit an article Journal homepage
126
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review

Benchalak Maneeton1 Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand, [email protected]Correspondence[email protected]
,
Narong Maneeton1 Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand, [email protected]
,
Surinporn Likhitsathian1 Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand, [email protected]
,
Pakapan Woottiluk2 Psychiatric Nursing Division, Faculty of Nursing, Chiang Mai University, Chiang Mai, Thailand
,
Punjaree Wiriyacosol1 Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand, [email protected]
,
Vudhichai Boonyanaruthee1 Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand, [email protected]
&
Manit Srisurapanont1 Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand, [email protected]
 show all
Pages 1953-1961 | Published online: 02 Aug 2018

References

  • CohenRMGreenbergJMIsHakWWIncorporating multidimensional patient-reported outcomes of symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression to measure treatment impact and recovery in MDDJAMA Psychiatry201370334335023303512
  • BostwickJMPankratzVSAffective disorders and suicide risk: a reexaminationAm J Psychiatry2000157121925193211097952
  • SteffensDCKrishnanKRHelmsMJAre SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysisDepress Anxiety19976110189394870
  • PapakostasGIHombergerCHFavaMA meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorderJ Psychopharmacol200822884384818308801
  • AndersonIMMeta-analytical studies on new antidepressantsBr Med Bull20015716117811719915
  • SchmittABBauerMVolzHPDifferential effects of venlafaxine in the treatment of major depressive disorder according to baseline severityEur Arch Psychiatry Clin Neurosci2009259632933919255709
  • SchuelerYBKoestersMWieselerBA systematic review of duloxetine and venlafaxine in major depression, including unpublished dataActa Psychiatr Scand2011123424726520831742
  • NierenbergAAGreistJHMallinckrodtCHDuloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority studyCurr Med Res Opin200723240141617288694
  • WadeAGembertKFloreaIA comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorderCurr Med Res Opin20072371605161417559755
  • KhanABoseAAlexopoulosGSGommollCLiDGandhiCDouble-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorderClin Drug Investig2007277481492
  • HigginsJPTAltmanDGAssessing risk of bias in included studiesHigginsJPTGreenSCochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (Updated March 2011)LondonThe Cochrane Collaboration2009
  • CiprianiAFurukawaTASalantiGComparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysisLancet2009373966574675819185342
  • PapakostasGITolerability of modern antidepressantsJ Clin Psychiatry200869Suppl E181318494538
  • WiebeNVandermeerBPlattRWKlassenTPMoherDBarrowmanNJA systematic review identifies a lack of standardization in methods for handling missing variance dataJ Clin Epidemiol200659434235316549255
  • SterneJACEggerMMoherDAddressing reporting biasesHigginsJPTGreenSCochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (Updated March 2011)LondonThe Cochrane Collaboration2009 Available from: http://handbook-5-1.cochrane.org/Accessed July 19, 2018
  • MallinckrodtCHPrakashAHoustonJPSwindleRDetkeMJFavaMDifferential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram)Neuropsychobiology2007562–3738518037817
  • WangJLiuXMullinsCDTreatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseasesCurr Med Res Opin20112771303131321561393
  • RaskinJGeorgeTGrangerREHussainNZhaoGWMarangellLBApathy in currently nondepressed patients treated with a SSRI for a major depressive episode: outcomes following randomized switch to either duloxetine or escitalopramJ Psychiatr Res201246566767422410206
  • RomeraIPérezVMenchónJMEarly switch strategy in patients with major depressive disorder: a double-blind, randomized studyJ Clin Psychopharmacol201232447948622722513
  • PigottTAPrakashAArnoldLMAaronsonSTMallinckrodtCHWohlreichMMDuloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorderCurr Med Res Opin20072361303131817559729
  • ManeetonNManeetonBEurviriyanukulKSrisurapanontMEfficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxineDrug Des Devel Ther2013710531062
  • CiprianiAKoestersMFurukawaTADuloxetine versus other anti-depressive agents for depressionCochrane Database Syst Rev201710CD006533
  • YılmazAEExamination of the metacognitive model of depression in a Turkish University student sampleTurk Psikiyatri Derg20162720 Turkish

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.